JP2022512922A5 - - Google Patents

Info

Publication number
JP2022512922A5
JP2022512922A5 JP2021524069A JP2021524069A JP2022512922A5 JP 2022512922 A5 JP2022512922 A5 JP 2022512922A5 JP 2021524069 A JP2021524069 A JP 2021524069A JP 2021524069 A JP2021524069 A JP 2021524069A JP 2022512922 A5 JP2022512922 A5 JP 2022512922A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
transmembrane domain
car
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021524069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512922A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/060005 external-priority patent/WO2020097164A1/en
Publication of JP2022512922A publication Critical patent/JP2022512922A/ja
Publication of JP2022512922A5 publication Critical patent/JP2022512922A5/ja
Pending legal-status Critical Current

Links

JP2021524069A 2018-11-06 2019-11-06 キメラ抗原受容体記憶様(carml)nk細胞ならびにその産生および使用方法 Pending JP2022512922A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862756294P 2018-11-06 2018-11-06
US62/756,294 2018-11-06
US201962788440P 2019-01-04 2019-01-04
US62/788,440 2019-01-04
PCT/US2019/060005 WO2020097164A1 (en) 2018-11-06 2019-11-06 Chimeric antigen receptor memory-like (carml) nk cells and methods of making and using same

Publications (2)

Publication Number Publication Date
JP2022512922A JP2022512922A (ja) 2022-02-07
JP2022512922A5 true JP2022512922A5 (cg-RX-API-DMAC7.html) 2022-11-14

Family

ID=70612473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524069A Pending JP2022512922A (ja) 2018-11-06 2019-11-06 キメラ抗原受容体記憶様(carml)nk細胞ならびにその産生および使用方法

Country Status (10)

Country Link
US (1) US20220073585A1 (cg-RX-API-DMAC7.html)
EP (1) EP3876961A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022512922A (cg-RX-API-DMAC7.html)
KR (1) KR20210090220A (cg-RX-API-DMAC7.html)
CN (1) CN113423409A (cg-RX-API-DMAC7.html)
AU (1) AU2019377461A1 (cg-RX-API-DMAC7.html)
CA (1) CA3117206A1 (cg-RX-API-DMAC7.html)
IL (1) IL282850A (cg-RX-API-DMAC7.html)
SG (1) SG11202104287RA (cg-RX-API-DMAC7.html)
WO (1) WO2020097164A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113226340A (zh) 2018-11-26 2021-08-06 恩卡尔塔公司 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途
KR20210137085A (ko) 2019-03-05 2021-11-17 엔카르타, 인크. Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
US11459372B2 (en) 2020-11-30 2022-10-04 Crispr Therapeutics Ag Gene-edited natural killer cells
EP4271798A1 (en) 2020-12-30 2023-11-08 CRISPR Therapeutics AG Compositions and methods for differentiating stem cells into nk cells
US20240115607A1 (en) * 2021-01-26 2024-04-11 Cytocares (Shanghai) Inc. Chimeric antigen receptor (car) constructs and nk cells expressing car constructs
WO2022171179A1 (zh) * 2021-02-10 2022-08-18 苏州克睿基因生物科技有限公司 一种扩增增强子及其应用
US20230330228A1 (en) 2022-03-22 2023-10-19 WUGEN, Inc. Hybrid promoters, vectors containing same and methods of use
WO2025067318A1 (zh) * 2023-09-28 2025-04-03 沛尔生技医药股份有限公司 具有细胞内信号传导结构域及自然杀伤蛋白30跨膜结构域的核酸分子及包含其的嵌合抗原受体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130266551A1 (en) * 2003-11-05 2013-10-10 St. Jude Children's Research Hospital, Inc. Chimeric receptors with 4-1bb stimulatory signaling domain
KR20140060541A (ko) * 2011-09-16 2014-05-20 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 암을 치료하기 위한 rna 조작된 t 세포
SG11201505858VA (en) * 2013-01-28 2015-09-29 St Jude Childrens Res Hospital A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
SG10202109752XA (en) * 2014-04-07 2021-10-28 Novartis Ag Treatment of cancer using anti-cd19 chimeric antigen receptor
AU2015292744C1 (en) * 2014-07-21 2021-01-21 Novartis Ag Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
ES2738705T3 (es) * 2014-09-19 2020-01-24 Hope City Linfocitos T de receptor de antígeno quimérico coestimulante que se dirigen a IL13R 2
CN113862292B (zh) * 2015-01-29 2024-12-27 明尼苏达大学董事会 嵌合抗原受体、组合物以及方法
US11932870B2 (en) * 2016-12-05 2024-03-19 Fate Therapeutics, Inc. Compositions and methods for immune cell modulation in adoptive immunotherapies
AU2018240556B2 (en) * 2017-03-24 2025-02-27 Lentigen Technology, Inc. Compositions and methods for treating cancer with anti-CD33 immunotherapy
KR102742741B1 (ko) * 2017-10-18 2024-12-16 프레시전 인코포레이티드 스페이서를 포함하는 폴리펩타이드 조성물
CN108219004A (zh) * 2018-02-08 2018-06-29 吉林省拓华生物科技有限公司 双特异嵌合抗原受体修饰的t细胞、其制备方法及用途
JP7723420B2 (ja) * 2019-08-28 2025-08-14 キングス・カレッジ・ロンドン B細胞標的化並列CAR(pCAR)治療的薬剤

Similar Documents

Publication Publication Date Title
US20240093232A1 (en) Retroviral And Lentiviral Vectors
Cerwenka et al. Natural killer cell memory in infection, inflammation and cancer
JP2025031794A5 (cg-RX-API-DMAC7.html)
CN107735407B (zh) 治疗剂
JP6695347B2 (ja) レトロウイルスおよびレンチウイルスベクター
JP2018526033A5 (cg-RX-API-DMAC7.html)
US20220064595A1 (en) Multi-target chimeric antigen receptor
JP2020058380A (ja) キメラ抗原受容体及びその製造方法
WO2022007795A1 (zh) 一种嵌合受体及其应用
CN114599785A (zh) 工程化的t细胞及其产生方法
RU2020117772A (ru) Векторы
JP2021500905A5 (cg-RX-API-DMAC7.html)
JP2024525609A5 (cg-RX-API-DMAC7.html)
EP3753566A1 (en) All-in one viral vector for car and therapeutic effector molecule
CN115835873A (zh) 用于产生表达重组受体的供体分批细胞的方法
CN117677633A (zh) 基于nkg2d的嵌合抗原受体
JP2024514942A5 (cg-RX-API-DMAC7.html)
CN119137262A (zh) 经改造细胞及使用方法
US20220118014A1 (en) Placenta-derived allogeneic car-t cells and uses thereof
CN121969385A (zh) 含有il-2变体以增强car t细胞的功能性的car-衔接子
US20240368626A1 (en) T-cell manufacturing methods
Mesci et al. A rapid and efficient method for the generation and screening of monoclonal antibodies specific for cell surface antigens
CN110863014A (zh) 改进的慢病毒载体
Ruddle T cell hybrids with specificity for individual antigens
RU2021116146A (ru) Nk-клетки с химерным антигенным рецептором, подобные клеткам памяти (carml), и способы их получения и примения